Publications

Related to the Economics and Epidemiology of HIV/AIDS, Tuberculosis, and Non-Communicable Diseases in Africa and Asia project

Thresholds for the cost–effectiveness of interventions: alternative approaches

Elliot Marseille, Bruce Larson, Dhruv S Kazi,James G Kahn, & Sydney Rosen

Bulletin of the World Health Organization. 2014 Dec; 1-16.

Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa

Alana T Brennan, Mhairi Maskew, Prudence Ive, Kate Shearer, Lawrence Long, Ian Sanne and Matthew P Fox

Journal of the International AIDS Society. 2013 Nov; 16(18794).

Effect of antiretroviral therapy on patients’ economic well-being: five-year follow up in South Africa

Sydney Rosen; Bruce Larson; Julia Rohr; Ian Sanne; Constance Mongwenyana; Alana T. Brennan; Omar Galárraga

AIDS. 2013 Sep;.

Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough

Bruce A. Larson, Kathryn Schnippel, Alana Brennan, Lawrence Long, Thembi Xulu, Thapelo Maotoe, Sydney Rosen, Ian Sanne, and Matthew P. Fox

AIDS Research and Treatment. 2013 Jun; 2013:1-7.

HE2RO Policy Brief 6: THE Benefits of Antiretroviral Therapy for Patients’ Economic Well-Being

Rosen S, Larson B, Rohr J, Sanne I, Mongwenyana C, Brennan AT, Galarraga O

2013 Jan.

Defining retention and attrition in pre-antiretroviral HIV care: proposals based on experience in Africa

Matthew P. Fox, Bruce Larson, and Sydney Rosen

Tropical Medicine and International Health. 2012 Aug; 00(00):1-10.

HIV Treatment Produces Economic Returns Through Increased Work And Education, And Warrants Continued US Support

Harsha Thirumurthy, Omar Galárraga, Bruce Larson, and Sydney Rosen

Health Affairs. 2012 Jul; 31(7):1470-1477.

Scaling up Xpert MTB⁄RIF technology: the costs of laboratory vs. clinic-based roll-out in South Africa

Kathryn Schnippel, Gesine Meyer-Rath, Lawrence Long, William MacLeod, Ian Sanne, Wendy S. Stevens and Sydney Rosen

Tropical Medicine and International Health. 2012 Jun; 00(00):1-10.

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa

Gesine Meyer-Rath, Kathryn Schnippel, Lawrence Long, William MacLeod, Ian Sanne, Wendy Stevens, Sagie Pillay, Yogan Pillay, Sydney Rosen

PLoS ONE. 2012 May; 7(5):1-11.

How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere PimaTM Analyzer in South Africa

Bruce Larson, Kathryn Schnippel, Buyiswa Ndibongo, Lawrence Long, Matthew P. Fox, & Sydney Rosen

PLoS ONE. 2012 Apr; 7(4):1-8.

Rapid, Point-of-Care CD4 Testing At Mobile and Fixed HIV Testing Sites: Does It Increase Linkage to HIV Care?

Larson B., Schnippel K., Ndibongo B., Brennan A., Xulu T., Long L., Fox M., Sanne I., Rosen S.

Health Economics and Epidemiology Research Office (HERO). 2011 Nov; 3:1-2.

Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort

Long L., Brennan A., Fox M.P., Ndibongo B., Jaffray I., Sanne I., Rosen S.

PLOS Medicine. 2011 Jul; 8(7):1-10.

Lost Opportunities to Complete CD4+ Lymphocyte Testing Among Patients Who Tested Positive for HIV in South Africa

Larson B.A., Brennan A., McNamara L., Long L., Rosen S., Sanne I., Fox M.P.

Bull World Health Organ. 2010 Sep; 88(9):675-80.